Child Health News

RSS

Fetuses exposed to high levels of stress hormone may have solving problems later on: Study

A mother's nurture may provide powerful protection against risks her baby faces in the womb, according to a new article published online today in the journal Biological Psychiatry. The research shows that fetuses exposed to high levels of stress hormone - shown to be a harbinger for babies' poor cognitive development - can escape this fate if their mothers provide them sensitive care during infancy and toddler-hood.

26 Feb 2010

Maternal sensitivity may influence language development among children in early stages of autism

A new study by researchers from the University of Miami shows that maternal sensitivity may influence language development among children who go on to develop autism. Although parenting styles are not considered as a cause for autism, this report examines how early parenting can promote resiliency in this population.

26 Feb 2010

BPA exposure during pregnancy may cause permanent reproduction problems for female offspring

Here's more evidence that "safe" plastics are not as safe as once presumed: New research published online in The FASEB Journal suggests that exposure to Bisphenol A (BPA) during pregnancy leads to epigenetic changes that may cause permanent reproduction problems for female offspring. BPA, a common component of plastics used to contain food, is a type of estrogen that is ubiquitous in the environment.

26 Feb 2010

New research using MRI shows that childhood stress can lead to structural brain changes

New research using magnetic resonance imaging (MRI) shows that childhood stress such as abuse or emotional neglect, in particular when combined with genetic factors, can result in structural brain changes, rendering these people more vulnerable to developing depression. The study led by scientists at Trinity College Dublin has just been published in the international scientific journal, Neuropsychopharmacology.

25 Feb 2010

CHOP and AIAM collaborate to develop more accurate child crash test dummies

A research report released today by The Children's Hospital of Philadelphia (CHOP) and the Association of International Automobile Manufacturers, Inc. (AIAM) details CHOP's cutting-edge work with academic and industry collaborators to develop more accurate child crash test dummies, called child anthropometric test devices (ATD's).

25 Feb 2010

YoNaturals' healthy nutrition agenda could help combat childhood obesity

Mark Trotter is the charismatic CEO of YoNaturals, the leader in natural and organic snack food vending. And he's led his feisty San Diego company on its own inspired mission to improve the diets of our nation's school age children.

25 Feb 2010

Nevirapine taken to protect fetus from HIV should be avoided for one year after childbirth, say researchers

Women given the human immunodeficiency virus (HIV) prevention drug nevirapine to protect their fetus should not use an HIV-drug regimen that contains nevirapine for at least one year after childbirth, say researchers at the University of Alabama at Birmingham.

25 Feb 2010

Arterial ischemic stroke in children often go unrecognized, and the strokes can recur

Children can have strokes, and the strokes can recur, usually within a month, according to pediatric researchers. Unfortunately, the strokes often go unrecognized the first time, and the child does not receive treatment before the recurrence.

25 Feb 2010

Deciphering babies' cries: Hope for new parents

Baby monitors of the future could translate infant cries, so that parents will know for certain whether their child is sleepy, hungry, needing a change, or in pain. Japanese scientists report details of a statistical computer program that can analyze a baby's crying in the International Journal of Biometrics.

25 Feb 2010

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine

Pfizer Inc. announced today that the United States Food and Drug Administration has granted approval for Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the Company’s 13-valent pneumococcal conjugate vaccine.

25 Feb 2010

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon’s PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.

24 Feb 2010

FDA approves Wyeth Pharmaceuticals' Prevnar 13 pneumococcal disease vaccine

The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.

24 Feb 2010

Genetic test for autism: Transgenomic licenses exclusive intellectual property from IntegraGen

Transgenomic, Inc. announced today that it has licensed on an exclusive U.S. basis intellectual property from IntegraGen SA that will enable Transgenomic to develop and commercialize a genetic test designed to assess the risk of autism in children who have older siblings diagnosed with an autism spectrum disorder. Under the agreement Transgenomic will develop the test in the Company's CAP-accredited and CLIA-certified laboratory, and anticipates launching the new test in the second quarter of 2010. Financial terms of the agreement were not disclosed.

24 Feb 2010

Frozen/thawed ovarian tissue transplant: Woman has two children from separate pregnancies

For the first time, a woman has given birth to two children after her fertility was restored using transplants of ovarian tissue that had been removed and frozen during her cancer treatment and then restored once she was cured.

24 Feb 2010

Women who become pregnant with single foetus after IVF/ICSI have increased risk of stillbirth

Women who become pregnant with a single foetus after in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) have an increased risk of a stillbirth, according to new research out today (Wednesday).

24 Feb 2010

New report identifies enormous global impact of preterm birth and stillbirth

A new report issued today identifies the enormous global impact of preterm birth and stillbirth-and what can be done to decrease it. Globally, an estimated 13 million babies are born preterm each year. Newborn deaths now account for more than 42 percent of mortality in children under the age of five, a rise from 37 percent in the year 2000.

24 Feb 2010

Prochymal achieves response rate of 63% when used as rescue therapy in children suffering from GvHD

Osiris Therapeutics, Inc. today reported that a new study shows Prochymal achieved an overall response rate of 63% when used as a rescue therapy in children suffering from severe treatment resistant graft vs. host disease (GvHD).

24 Feb 2010

Early implantation of cochlear devices in deaf children leads to better overall quality of life

Profoundly deaf children with cochlear implants to help them to hear rate their quality of life equal to their normal-hearing peers, according to new research from UT Southwestern Medical Center auditory specialists.

24 Feb 2010

New non-neurotoxic treatment for head lice in children

A new non-neurotoxic treatment for head lice has been found to have an average of 91.2% treatment success rate after one week, and to be safe in humans from six months of age and up. This is the finding of a study published today in Pediatric Dermatology.

24 Feb 2010

ELARC terminates DIR for children with autism: Court orders reinstatement

The Los Angeles Superior Court yesterday issued a preliminary injunction in the class action lawsuit filed on behalf of children with autism against the Eastern Los Angeles Regional Center (ELARC) for unlawfully terminating the most effective treatment for their condition.

24 Feb 2010

Child Health News

Fetuses exposed to high levels of stress hormone may have solving problems later on: Study

Maternal sensitivity may influence language development among children in early stages of autism

BPA exposure during pregnancy may cause permanent reproduction problems for female offspring

New research using MRI shows that childhood stress can lead to structural brain changes

CHOP and AIAM collaborate to develop more accurate child crash test dummies

YoNaturals' healthy nutrition agenda could help combat childhood obesity

Nevirapine taken to protect fetus from HIV should be avoided for one year after childbirth, say researchers

Arterial ischemic stroke in children often go unrecognized, and the strokes can recur

Deciphering babies' cries: Hope for new parents

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

FDA approves Wyeth Pharmaceuticals' Prevnar 13 pneumococcal disease vaccine

Genetic test for autism: Transgenomic licenses exclusive intellectual property from IntegraGen

Frozen/thawed ovarian tissue transplant: Woman has two children from separate pregnancies

Women who become pregnant with single foetus after IVF/ICSI have increased risk of stillbirth

New report identifies enormous global impact of preterm birth and stillbirth

Prochymal achieves response rate of 63% when used as rescue therapy in children suffering from GvHD

Early implantation of cochlear devices in deaf children leads to better overall quality of life

New non-neurotoxic treatment for head lice in children

ELARC terminates DIR for children with autism: Court orders reinstatement

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News